COSCIENS Biopharma Inc. is gaining traction on the TSX as investors respond positively to recent developments.
COSCIENS Biopharma Inc. (CSCI.TO) is rising today, with shares up by 3.15% to a closing price of CA$7.86. The market cap stands at approximately CA$8 million, reflecting investor optimism despite the absence of significant news.
Investor takeaway: The rise in COSCIENS Biopharma's stock price could indicate growing confidence among investors, even in the absence of major announcements.
Advertisement
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
WealthAwesomeAdvertisement
Market cap
$8.09M
52W high
$14.80
52W low
$3.30
1W change
+11.17%
Beta
1.89
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
573.7%
Annualized
90-Day Vol
339.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.40
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.34 | C$1.15 – C$60.39 |
| 60 trading days | C$8.85 | C$0.54 – C$145.53 |
| 90 trading days | C$9.40 | C$0.30 – C$289.78 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
3.15% Increase in Stock Price
COSCIENS Biopharma Inc.'s stock has appreciated by 3.15% today, reflecting a positive market response.
Bull case
Investors might feel encouraged by the company's recent strategic moves and its potential in the biopharma sector. This optimism could lead to sustained interest and further price increases.
Bear case
However, without substantial news or updates on financial performance, this stock rise may be speculative. It could become vulnerable to corrections if investor sentiment changes.
Advertisement
Market Performance Overview
COSCIENS Biopharma Inc. is seeing a positive shift in its stock performance today, with a rise of 3.15%. This increase comes as the market reacts to the company’s ongoing efforts to enhance its position in the biopharma sector.
Investor Sentiment and Future Outlook
The increase in COSCIENS Biopharma's stock price may reflect a growing confidence among investors regarding the company's future prospects. However, the lack of recent announcements means that investors should remain cautious and monitor any developments closely.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
